Prime Medicine Management
Management criteria checks 1/4
Prime Medicine's CEO is Keith Gottesdiener, appointed in Jul 2020, has a tenure of 4.33 years. total yearly compensation is $5.40M, comprised of 11.6% salary and 88.4% bonuses, including company stock and options. directly owns 3.42% of the company’s shares, worth $13.96M. The average tenure of the management team and the board of directors is 2.3 years and 3 years respectively.
Key information
Keith Gottesdiener
Chief executive officer
US$5.4m
Total compensation
| CEO salary percentage | 11.6% |
| CEO tenure | 4.3yrs |
| CEO ownership | 3.4% |
| Management average tenure | 2.3yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
Prime Medicine's Promising Pipeline: PM359 And Cash Burn Concerns
Sep 04Here's Why We're A Bit Worried About Prime Medicine's (NASDAQ:PRME) Cash Burn Situation
Sep 04
Prime Medicine Stock: Only For The Most Patient Of Investors
Jun 20Is Prime Medicine (NASDAQ:PRME) In A Good Position To Invest In Growth?
May 14Prime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing
Jan 28Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?
Aug 25We're Not Very Worried About Prime Medicine's (NASDAQ:PRME) Cash Burn Rate
May 12Will Prime Medicine (NASDAQ:PRME) Spend Its Cash Wisely?
Jan 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$219m |
| Jun 30 2024 | n/a | n/a | -US$217m |
| Mar 31 2024 | n/a | n/a | -US$204m |
| Dec 31 2023 | US$5m | US$625k | -US$198m |
| Sep 30 2023 | n/a | n/a | -US$173m |
| Jun 30 2023 | n/a | n/a | -US$158m |
| Mar 31 2023 | n/a | n/a | -US$151m |
| Dec 31 2022 | US$924k | US$542k | -US$142m |
| Sep 30 2022 | n/a | n/a | -US$171m |
| Jun 30 2022 | n/a | n/a | -US$158m |
| Mar 31 2022 | n/a | n/a | -US$126m |
| Dec 31 2021 | US$3m | US$524k | -US$184m |
| Sep 30 2021 | n/a | n/a | -US$118m |
| Dec 31 2020 | US$935k | US$252k | -US$5m |
Compensation vs Market: Keith's total compensation ($USD5.40M) is above average for companies of similar size in the US market ($USD2.18M).
Compensation vs Earnings: Keith's compensation has increased whilst the company is unprofitable.
CEO
Keith Gottesdiener (70 yo)
4.3yrs
Tenure
US$5,403,071
Compensation
Dr. Keith Michael Gottesdiener, Ph D, serves as Venture Partner at Samsara Biocapital, LLC. He serves as the President & Secretary at Prime Medicine, Inc and also serves as a Director and Chief Executive O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$5.40m | 3.42% $ 14.0m | |
| Chief Technical Officer | 3.1yrs | US$2.26m | 0% $ 0 | |
| Chief Scientific Officer | 3.8yrs | US$2.26m | 0.76% $ 3.1m | |
| Co-Founder & Head of Prime Editing Platform | no data | no data | no data | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | 15.8% $ 64.5m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior VP and Head of Strategy & Corporate Operations | 4.2yrs | no data | no data | |
| Senior VP of Finance & Chief Accounting Officer | 2.2yrs | no data | no data | |
| Senior Vice President of Intellectual Property & Legal Affairs | no data | no data | no data | |
| Chief Human Resources Officer | 2.3yrs | no data | no data | |
| Chief Business Officer | 2.3yrs | US$1.67m | 0% $ 0 | |
| Senior VP & Head of Regulatory Affairs | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
57yo
Average Age
Experienced Management: PRME's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$5.40m | 3.42% $ 14.0m | |
| Co-Founder & Member of Scientific Advisory Board | 2.3yrs | no data | 15.8% $ 64.5m | |
| Independent Director | 4.2yrs | US$445.46k | 0.013% $ 51.4k | |
| Independent Director | 3yrs | US$454.46k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$451.46k | 0% $ 0 | |
| Independent Director | 5.2yrs | US$455.46k | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 3yrs | US$451.96k | 0% $ 0 | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 3yrs | US$451.96k | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data |
3.0yrs
Average Tenure
64yo
Average Age
Experienced Board: PRME's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.